Literature DB >> 20417572

Sex differences in patients with schizophrenia: A prospective, multi-center study.

Yu-Tao Xiang1, Chuan-Yue Wang, Yong-Zhen Weng, Qi-Jing Bo, Helen F K Chiu, Jing-Ping Zhao, Tie-Qiao Liu, Sandra S M Chan, Edwin H M Lee, Gabor S Ungvari.   

Abstract

This study aimed to determine sex differences in socio-demographic and clinical characteristics of Chinese schizophrenia patients. In a multi-center, randomized, controlled, longitudinal study, 404 clinically stable patients with schizophrenia were randomly assigned to a maintenance group (optimal therapeutic doses continued throughout the study), a 26-week group (optimal therapeutic doses continued for 26 weeks, followed by a 50% dose reduction maintained until the end of the study), or a 4-week group (optimal therapeutic doses continued for 4 weeks, followed by a 50% dose reduction maintained until the end of the study). Participants were interviewed regularly using standardized assessment instruments, and followed up for 12-26 months. In the univariate analyses, the following factors were significantly associated with the male sex: not married, smoking, younger age, earlier age at onset, higher body mass index (BMI) at baseline, and more severe negative and hostility-excitement symptoms at baseline. The following factors were independently associated with the male sex in the multivariate analyses: not being married, smoking, a higher BMI at baseline, less deterioration in disorganized thoughts (4-week group) and positive symptoms (26-week group) and less increase in BMI in all three treatment groups over the study period. The majority of the sex differences in schizophrenia patients in this study are in accordance with results of previous studies worldwide suggesting that sex differences seen in schizophrenia are not dependent on cultural differences between geographically separate patients. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417572     DOI: 10.1016/j.psychres.2010.03.014

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

Review 1.  The immune system as a novel regulator of sex differences in brain and behavioral development.

Authors:  Lars H Nelson; Kathryn M Lenz
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

2.  Importance of gender in the treatment of schizophrenia.

Authors:  Eva Ceskova; Radovan Prikryl
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-15

3.  A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.

Authors:  Kristina M Deligiannidis; Anthony J Rothschild; Bruce A Barton; Aimee R Kroll-Desrosiers; Barnett S Meyers; Alastair J Flint; Ellen M Whyte; Benoit H Mulsant
Journal:  J Clin Psychiatry       Date:  2013-10       Impact factor: 4.384

4.  Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.

Authors:  Qijing Bo; Fang Dong; Xianbin Li; Zhimin Wang; Xin Ma; Chuanyue Wang
Journal:  BMC Psychiatry       Date:  2016-11-09       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.